NCT04424225View on ClinicalTrials.gov

Visual Surround Suppression and Perceptual Expectation Under Psilocybin

PHASE1TerminatedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

August 30, 2021

Primary Completion Date

September 1, 2023

Study Completion Date

September 1, 2023

Conditions
Perception DisturbanceVisual SuppressionPsychedelic Experiences
Interventions
DRUG

Psilocybin

25 mg capsules (white opaque, Capsugel Vcaps Plus HPMC size 2)

DRUG

Niacin

100 mg capsules (white opaque, Capsugel Vcaps Plus HPMC size 2)

Trial Locations (1)

55455

University of Minnesota, Minneapolis

Sponsors
All Listed Sponsors
collaborator

Heffter Research Institute

OTHER

lead

University of Minnesota

OTHER

NCT04424225 - Visual Surround Suppression and Perceptual Expectation Under Psilocybin | Biotech Hunter | Biotech Hunter